July 28, 2014
This Hepatitis Day, the 185 million people worldwide living with chronic Hepatitis C (HCV) and their loved ones ought to be celebrating a major medical accomplishment: the release of sofosbuvir, a new medication which cured 90% of HCV-infected patients in clinical trials. It is too soon to celebrate, however, as this life-saving drug remains financially out of reach for most of those affected.
July 17, 2014
Hesperian offers our deepest condolences to the family and friends of those lost in Malaysia Airlines flight MH17. We are deeply saddened by the loss of many outstanding members of the HIV/AIDS research community and civil society.
There are currently 3.34 million children living with HIV worldwide. Recent studies demonstrate that gaps in access to treatment are widening in countries with high rates of HIV infection, with only 34% of children in surveyed countries being given Anti-Retroviral Therapy (ART) medicines, as opposed to 68% of adults. The problem becomes even more complex when you consider the 70 million children who become caregivers for their families at an early age, are orphaned, or experience a wide array of detrimental social impacts from growing up in communities disproportionately affected by HIV.
June 26, 2014
Historically, trans* communities have been one of the most medically underserved populations in the United States. With the passage of the Affordable Care Act (ACA), trans* people have greater access to health care than ever before. However, insurance coverage is not enough to ensure quality care, as medical settings have a long legacy of excluding and alienating transgender and gender-variant people.